Results 151 to 160 of about 28,085 (215)

Renaissance of Phoenix Drug Thalidomide-New Insights into Practical Clinical Application and Optimization Strategies for Managing Adverse Effects in Digestive Diseases. [PDF]

Pharmaceuticals (Basel)
Yan X, Guo Z, Lyu C, Tang R, Li R, Wang H, Song K, Chen W, He K, Wu D.   +9 more
europepmc   +1 more source

Multi-omics Analysis Reveals the Correlation of Gut Microbiota and Metabolites With Thalidomide Treatment for Chemotherapy-Induced Nausea and Vomiting in Small Cell Lung Cancer. [PDF]

Biotechnol J
Sun QG, Zang D, Xin Y, Cui J, Han X, Chen J.   +5 more
europepmc   +1 more source

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study. [PDF]

EJHaem
Silfverberg T, Cherif H, Smitt E, Carlson K.   +3 more
europepmc   +1 more source

Biological Drivers of IMiD-Induced Peripheral Neuropathy in Multiple Myeloma. [PDF]

EJHaem
Beer SA, Houlston R, Kaiser MF.
europepmc   +1 more source

Opportunities and barriers for innovation at the interface of engineering and maternal-fetal medicine. [PDF]

Commun Eng
Howlett TS, Parchem JG, Swingle KL.
europepmc   +1 more source

Pomalidomide re-exposure after drug-related severe hypothyroidism: a case report. [PDF]

Ann Hematol
Bartolomei F, Za T, Di Landro F, De Stefano V, Rossi E.   +4 more
europepmc   +1 more source

Bradyarrhythmias Associated with Oncologic Treatment-An Updated Review. [PDF]

Cancers (Basel)
Stępień J, Stępniak-Bielecka J, Ciołek A, Piotrowski J, Kryca A, Piotrowski G.   +5 more
europepmc   +1 more source

Correction: Discovery and optimization of tau targeted protein degraders enabled by patient induced pluripotent stem cells-derived neuronal models of tauopathy. [PDF]

Front Cell Neurosci
Silva MC, Nandi G, Donovan KA, Cai Q, Berry BC, Nowak RP, Fischer ES, Gray NS, Ferguson FM, Haggarty SJ.   +9 more
europepmc   +1 more source

Flow-induced Klf4-Akt signaling links EC cycling to mural cell defects in arterial-venous malformations. [PDF]

Theranostics
Lin Y, Hashemi Z, Zhang Q, Di Y, Behera T, Gahn J, Banerjee K, Wu F, Andorfer K, Singhal M, Seebauer C, Ola R.   +11 more
europepmc   +1 more source

Context Matters: E3 Ligase-Ligand Pairing Strategies for Optimized PROTAC Performance. [PDF]

Protein Cell
Yin L, Shu P, Peng X.
europepmc   +1 more source